Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bladder cancer

Towards risk stratification in bladder cancer

Bladder cancer risk assessment is currently based on an individual's age and history of exposure to known carcinogens. A new report illustrates how interactions between cigarette smoking and germline genetic variation can identify those at particularly high risk, who could be targeted in future bladder cancer prevention and screening efforts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Garcia-Closas, M. et al. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res. 73, 2211–2220 (2013).

    Article  CAS  PubMed Central  Google Scholar 

  2. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).

    Article  PubMed Central  Google Scholar 

  3. Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A. & Abnet, C. C. Association between smoking and risk of bladder cancer among men and women. JAMA 306, 737–745 (2011).

    Article  CAS  PubMed Central  Google Scholar 

  4. Barocas, D. A. et al. Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Adv. Urol. 2012, 421709 (2012).

    Article  PubMed Central  Google Scholar 

  5. Bochner, B. H., Kattan, M. W. & Vora, K. C. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24, 3967–3972 (2006).

    Article  PubMed Central  Google Scholar 

  6. Vickers, A. J. et al. Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 119, 143–149 (2013).

    Article  PubMed Central  Google Scholar 

  7. Kiemeney, L. A., Grotenhuis, A. J., Vermeulen, S. H. & Wu, X. Genome-wide association studies in bladder cancer: first results and potential relevance. Curr. Opin. Urol. 19, 540–546 (2009).

    Article  PubMed Central  Google Scholar 

  8. Wu, X., Hildebrandt, M. A. & Chang, D. W. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications. Cancer Metastasis Rev. 28, 269–280 (2009).

    Article  PubMed Central  Google Scholar 

  9. Park, J. H., Gail, M. H., Greene, M. H. & Chatterjee, N. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J. Clin. Oncol. 30, 2157–2162 (2012).

    Article  PubMed Central  Google Scholar 

  10. Surveillance Epidemiology and End Results Database. SEER Cancer Statistics Review 1975–2009 [online], (2013).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernard H. Bochner.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Furberg, H., Bochner, B. Towards risk stratification in bladder cancer. Nat Rev Urol 10, 374–375 (2013). https://doi.org/10.1038/nrurol.2013.114

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2013.114

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing